Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 25, 2024 10:01am
WARNING: Do NOT under sell your LABS shares. We have a
real life comparable: Astrazeneca paid $21 per share for FUSN, a 'payload' delivery mechanism only. If LABS only hits home runs on 25% their 'strong clinical trials'
...more
(548)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 25, 2024 9:56am
RE:RE:RE:Shake baby Shake :) Targets of $5.10 - $5.60 :)
why dont you 2 take it to the board this belongs to this is not about LABS
(517)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Comment by
1hot-techwoman
on Mar 25, 2024 9:53am
RE:RE:Shake baby Shake :) Targets of $5.10 - $5.60 :)
Missed the low by a bit but not worried Subaru :) Be nice now..... :)
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 25, 2024 9:50am
RE:Shake baby Shake :) Targets of $5.10 - $5.60 :)
...you're such a 'naugty' girl. :-)
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 25, 2024 9:49am
Afternoon session break out?
I sense a new 52 week high today driven by some institutional buying.
(517)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 25, 2024 9:43am
Shake baby Shake :) Targets of $5.10 - $5.60 :)
19 Bullish Most Recent Target 5.10 - 5.60 2 Bearish Most Recent Target 0.20 - 1.10 Support & Resistance Support found
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 25, 2024 9:43am
David, thanks for the update and please don't forget to do
the same when the DEA reschedules. Thanks in advance, Athea and Ed.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 25, 2024 9:41am
Like LABS business in Germany, I see we are "very robust"
here today as well. After Germany 'rescheduling', I'm pretty sure Vice President Kamala Harris told us the DEA is next for the U.S. market. PLEASE, do not forget
...more
(548)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 25, 2024 9:40am
RE:RE:How deep is the relationship between LABS & traditional
ya i agree he sometimes he does post useful stuff but when he gets into the whole universe his alien GF Mumbo Jumbo i start to scrach my head and think whats this guy on ?! he put me on Ignore
...more
(517)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Comment by
1hot-techwoman
on Mar 25, 2024 9:39am
RE:MediPharm poised to profit from German cannabis legalization
Very Nice !! :) Adding more to go long :) GLTA
(482)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Mar 25, 2024 9:36am
MediPharm poised to profit from German cannabis legalization
https://stockhouse.com/news/the-market-online-news/2024/03/25/medipharm-poised-to-profit-from-german-cannabis-legalization
(548)
•••
okgonow
X
View Profile
View Bullboard History
Post by
okgonow
on Mar 25, 2024 9:32am
not since
not since Oct 2019 has LABS short report position been this low Symbol Issue Name Shares Net Change Date $LABS.TO MEDIPHARM LABS
...more
(48)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 25, 2024 9:26am
RE:How deep is the relationship between LABS & traditional
Nothing you stated in your post is mathematics, let be clear. The first part of your post where the CEO stated debt free and owning assets, that is fact. Everything else after that is just blather
...more
(48)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 25, 2024 9:20am
RE:RE:How deep is the relationship between LABS & traditional
No way no how does LABS do $25mil in Q4. But depending on how the dominoes drop in Brazil and Germany, they can start getting far closer in a Q or two.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year
Strong Q1 and Muscular Q2 Outlook for Cannabis Edibles Leader